4-butyrolactone has been researched along with n-formylmethionine leucyl-phenylalanine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, IS; Day, YJ; Huang, YJ; Liao, CH; Lin, YC; Tseng, CP | 1 |
| Araujo, EVO; de Sousa, JAC; Guimaraes, MA; Leal, LKAM; Leite, JRSA; Lima, DF; Machado, NJ; Rocha, TM | 1 |
2 other study(ies) available for 4-butyrolactone and n-formylmethionine leucyl-phenylalanine
| Article | Year |
|---|---|
(2R,3R)-2-(3',4'-dihydroxybenzyl)-3-(3'',4''-dimethoxybenzyl)butyrolactone suppresses fMLP-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
Topics: 4-Butyrolactone; Adult; Calcium; Cyclic AMP; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Lignans; Macrophage-1 Antigen; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphorylation; Piper; Receptors, Formyl Peptide; Superoxides | 2008 |
Imidazole alkaloids inhibit the pro-inflammatory mechanisms of human neutrophil and exhibit anti-inflammatory properties in vivo.
Topics: 4-Butyrolactone; Alkaloids; Animals; Anti-Inflammatory Agents; Calcium; Humans; Hyperalgesia; Imidazoles; Interleukin-6; Male; Mice; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; NF-kappa B; Peroxidase; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2019 |